Reducing CD73 expression by IL1β-Programmed Th17 cells improves immunotherapeutic control of tumors.
about
CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppressionExploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinicInhibition of Tumor Growth and Immunomodulatory Effects of Flavonoids and Scutebarbatines of Scutellaria barbata D. Don in Lewis-Bearing C57BL/6 Mice.1α,25-dihydroxyvitamin D3 acts via transforming growth factor-β to up-regulate expression of immunosuppressive CD73 on human CD4+ Foxp3- T cellsCD73 is expressed by inflammatory Th17 cells in experimental autoimmune encephalomyelitis but does not limit differentiation or pathogenesis.CD73-adenosine: a next-generation target in immuno-oncology.The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets.Lack of p53 Augments Antitumor Functions in Cytolytic T Cells.CD73-mediated adenosine production promotes stem cell-like properties in mouse Tc17 cells.Synthetic RORγ agonists regulate multiple pathways to enhance antitumor immunity.T Helper 17 Promotes Induction of Antigen-Specific Gut-Mucosal Cytotoxic T Lymphocytes following Adenovirus Vector Vaccination.Inhibiting Oxidative Phosphorylation In Vivo Restrains Th17 Effector Responses and Ameliorates Murine Colitis.Expression of ectonucleotidases in the prosencephalon of melatonin-proficient C3H and melatonin-deficient C57Bl mice: spatial distribution and time-dependent changes.CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response.
P2860
Q26801436-59971138-BE17-440E-92B0-8CE6525EE380Q28075992-69CBC924-17B2-4F58-86AC-5C044F8338ACQ35612583-C769B6FD-05DB-457D-9AF4-15A8F8470DD9Q36176421-AB7682B6-4958-45D8-A703-AD9CCBA33A35Q36306232-3F037089-A557-4F2A-AB14-FCCB4AAB93C8Q38711094-A0580DAF-F9BE-4703-8209-2390377379A0Q39161005-C803DA10-F283-43F9-9076-2D6D0349BADFQ39551937-246C0C28-4FA9-4DE9-9183-E945F5B3EDA9Q40583105-54EFE0D4-D5C7-472A-BDB0-48D3E5C8DEEFQ40806737-B79F777E-6874-4319-8363-04B5D4C5125DQ44133482-FF3523F8-DF25-420B-B614-68DD1A93D899Q48046289-5F42271D-0737-41BB-AD0B-B57A9F4FF6F1Q48185437-73FEE6B5-605D-4D06-AFD5-C16F4C9072C2Q50054341-415AAD96-6DDC-41B0-8249-65BD80E993F1
P2860
Reducing CD73 expression by IL1β-Programmed Th17 cells improves immunotherapeutic control of tumors.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Reducing CD73 expression by IL ...... therapeutic control of tumors.
@en
type
label
Reducing CD73 expression by IL ...... therapeutic control of tumors.
@en
prefLabel
Reducing CD73 expression by IL ...... therapeutic control of tumors.
@en
P2093
P2860
P50
P1433
P1476
Reducing CD73 expression by IL ...... otherapeutic control of tumors
@en
P2093
Andrew S Kraft
Chenthamarkshan Vasu
Chrystal M Paulos
Krishnamurthy Thyagarajan
Myroslawa Soloshchenko
Shikhar Mehrotra
Shilpak Chatterjee
Xue-Zhong Yu
P2860
P304
P356
10.1158/0008-5472.CAN-14-1450
P407
P577
2014-09-09T00:00:00Z